ArticleExperimental and therapeutic medicine2015

Silencing of TGM2 reverses epithelial to mesenchymal transition and modulates the chemosensitivity of breast cancer to docetaxel.

Wenxing He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.